16-68157893-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173165.3(NFATC3):c.1426A>G(p.Ile476Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,613,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173165.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFATC3 | NM_173165.3 | c.1426A>G | p.Ile476Val | missense_variant | 4/10 | ENST00000346183.8 | |
NFATC3 | NM_004555.4 | c.1426A>G | p.Ile476Val | missense_variant | 4/11 | ||
NFATC3 | NM_173163.3 | c.1426A>G | p.Ile476Val | missense_variant | 4/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFATC3 | ENST00000346183.8 | c.1426A>G | p.Ile476Val | missense_variant | 4/10 | 1 | NM_173165.3 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.000105 AC: 16AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250828Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135574
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461198Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 726860
GnomAD4 genome ? AF: 0.000105 AC: 16AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.1426A>G (p.I476V) alteration is located in exon 4 (coding exon 4) of the NFATC3 gene. This alteration results from a A to G substitution at nucleotide position 1426, causing the isoleucine (I) at amino acid position 476 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at